Anthracycline therapy has been the cornerstone of many chemotherapy regimens for pediatric patients, since its introduction in the 1960s. Cardiotoxicity is the main dose limiting side effect that was reported a decade after its first use [7,8,9,10]. While the mechanisms of anthracycline cardiotoxic...